677 related articles for article (PubMed ID: 1330165)
1. Response to atrial natriuretic peptide, endopeptidase 24.11 inhibitor and C-ANP receptor ligand in the rat.
Wilkins MR; Settle SL; Kirk JE; Taylor SA; Moore KP; Unwin RJ
Br J Pharmacol; 1992 Sep; 107(1):50-7. PubMed ID: 1330165
[TBL] [Abstract][Full Text] [Related]
2. Effect of endopeptidase-24.11 inhibition and of atrial natriuretic peptide clearance receptor ligand on the response to rat brain natriuretic peptide in the conscious rat.
Kirk JE; Wilkins MR
Br J Pharmacol; 1993 Sep; 110(1):350-4. PubMed ID: 8220896
[TBL] [Abstract][Full Text] [Related]
3. Natriuretic response to neutral endopeptidase inhibition is blunted by enalapril in healthy men.
Motwani JG; Lang CC; Cramb G; Struthers AD
Hypertension; 1995 Apr; 25(4 Pt 1):637-42. PubMed ID: 7721409
[TBL] [Abstract][Full Text] [Related]
4. Pressure-dependent, enhanced natriuretic response to low-dose, atrial natriuretic peptide infusion in essential hypertension.
Eiskjaer H; Nielsen CB; Pedersen EB
J Intern Med; 1994 Dec; 236(6):665-74. PubMed ID: 7989902
[TBL] [Abstract][Full Text] [Related]
5. Effects of the selective neutral endopeptidase inhibitor, retrothiorphan, on renal function and blood pressure in conscious normotensive Wistar and hypertensive DOCA-salt rats.
Pham I; el Amrani AI; Fournié-Zaluski MC; Corvol P; Roques B; Michel JB
J Cardiovasc Pharmacol; 1992 Dec; 20(6):847-57. PubMed ID: 1282584
[TBL] [Abstract][Full Text] [Related]
6. Renal effects of atrial natriuretic peptide infusion in young and adult rats.
Chevalier RL; Gomez RA; Carey RM; Peach MJ; Linden JM
Pediatr Res; 1988 Sep; 24(3):333-7. PubMed ID: 2850523
[TBL] [Abstract][Full Text] [Related]
7. Comparison of renal actions of urodilatin and atrial natriuretic peptide.
Hildebrandt DA; Mizelle HL; Brands MW; Hall JE
Am J Physiol; 1992 Mar; 262(3 Pt 2):R395-9. PubMed ID: 1313650
[TBL] [Abstract][Full Text] [Related]
8. Neutral endopeptidase inhibition potentiates the effects of natriuretic peptides in renin transgenic rats.
Wegner M; Ganten D; Stasch JP
Hypertens Res; 1996 Dec; 19(4):229-38. PubMed ID: 8986453
[TBL] [Abstract][Full Text] [Related]
9. Renal and hormonal actions of atrial natriuretic peptide during angiotensin II or noradrenaline infusion in man.
Eiskjaer H; Nielsen CB; Sørensen SS; Pedersen EB
Eur J Clin Invest; 1996 Jul; 26(7):584-95. PubMed ID: 8864421
[TBL] [Abstract][Full Text] [Related]
10. Renal effects of neutral endopeptidase inhibition in euvolemic and hypervolemic rats.
Scott JM; Barclay PL; Shepperson NB
Eur J Pharmacol; 1993 Sep; 242(1):91-7. PubMed ID: 8223941
[TBL] [Abstract][Full Text] [Related]
11. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
Eiskjaer H; Nielsen CB; Pedersen EB
J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
[TBL] [Abstract][Full Text] [Related]
12. Enhanced natriuretic response to neutral endopeptidase inhibition in patients with moderate chronic renal failure.
Lipkin GW; Dawnay AB; Harwood SM; Cattell WR; Raine AE
Kidney Int; 1997 Sep; 52(3):792-801. PubMed ID: 9291201
[TBL] [Abstract][Full Text] [Related]
13. Acute reversal of cyclosporine nephrotoxicity by neutral endopeptidase inhibition in stable renal transplant recipients.
Lipkin GW; Thuraisingham R; Dawnay AB; Harwood SM; Raine AE
Transplantation; 1997 Oct; 64(7):1007-17. PubMed ID: 9381523
[TBL] [Abstract][Full Text] [Related]
14. Thiorphan, an inhibitor of endopeptidase 24.11, potentiates the natriuretic activity of atrial natriuretic peptide.
Trapani AJ; Smits GJ; McGraw DE; Spear KL; Koepke JP; Olins GM; Blaine EH
J Cardiovasc Pharmacol; 1989 Sep; 14(3):419-24. PubMed ID: 2476621
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of neutral endopeptidase potentiates the effects of atrial natriuretic peptide on acute cyclosporin-induced nephrotoxicity.
Capasso G; Unwin R; Ciani F; Rizzo A; Russo F; Pica A; De Santo NG
Nephron; 2000 Nov; 86(3):298-305. PubMed ID: 11096287
[TBL] [Abstract][Full Text] [Related]
16. Dose-response study of atrial natriuretic peptide bolus injection in healthy man.
Eiskjaer H; Pedersen EB
Eur J Clin Invest; 1993 Jan; 23(1):37-45. PubMed ID: 8383057
[TBL] [Abstract][Full Text] [Related]
17. Phosphodiesterase inhibitors correct resistance to natriuretic peptides in rats with Heymann Nephritis.
Valentin JP; Ying WZ; Sechi LA; Ling KT; Qiu C; Couser WG; Humphreys MH
J Am Soc Nephrol; 1996 Apr; 7(4):582-93. PubMed ID: 8724892
[TBL] [Abstract][Full Text] [Related]
18. Four-hour atrial natriuretic peptide infusion in conscious rats: effects on urinary volume, sodium, and cyclic GMP.
Campbell HT; Lightfoot BO; Sklar AH
Proc Soc Exp Biol Med; 1988 Dec; 189(3):317-24. PubMed ID: 2849771
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the natriuretic response to atrial natriuretic peptide by alterations in peritubular Starling forces in the rat.
Mendez RE; Dunn BR; Troy JL; Brenner BM
Circ Res; 1986 Dec; 59(6):605-11. PubMed ID: 2949885
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of ANP clearance receptors and endopeptidase 24.11 in maturing rats.
Chevalier RL; Garmey M; Scarborough RM; Linden J; Gomez RA; Peach MJ; Carey RM
Am J Physiol; 1991 Jun; 260(6 Pt 2):R1218-28. PubMed ID: 1647702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]